2 results
Not approvedWill not start
Primary:To compare the efficacy of abrocitinib 200 mg once daily (QD) versus dupilumab (as per label guidelines) in adult participants on background topical therapy with moderate to severe atopic dermatitis (AD).Key SecondaryTo compare the efficacy…
Approved WMOCompleted
To test the effectiveness of an online self-help training with adherence focused guidance on reducing cannabis use and increasing treatment service utilization in a sample of frequent cannabis users in a RCT. Primary objectiveTo test if an internet-…